endocrine/exocrine glands
• pioglitazone-fed mice exhibit lipid accumulation in thyroid cells
|
• 100-fold increase in size
• larger than in Ptentm1Hwu/Ptentm1Hwu Tg(TPO-cre)1Shk mice
• irregularly shaped, mutlinodular, more cellular than colloid
• however, pioglitazone (a PPARG inhibitor) decreases thyroid size
|
• with metastasis to the lungs and soft tissues
• however, pioglitazone (a PPARG inhibitor) induces a lipogenic antitumor response
|
• pioglitazone-fed mice exhibit decreased thyroid size due to increased apoptosis
|
homeostasis/metabolism
• 6-fold
• however, pioglitazone normalizes thyroid function
|
• 3.5-fold
• however, pioglitazone normalizes thyroid function
|
neoplasm
• with metastasis to the lungs and soft tissues
• however, pioglitazone (a PPARG inhibitor) induces a lipogenic antitumor response
|
immune system
• pioglitazone-fed mice exhibit decreased thyroid size due to increased apoptosis
|
hematopoietic system
• pioglitazone-fed mice exhibit decreased thyroid size due to increased apoptosis
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
thyroid gland carcinoma | DOID:3963 | J:177181 |